These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
837 related items for PubMed ID: 11805567
1. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Lindberg BU, Broomé U, Persson B. Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567 [Abstract] [Full Text] [Related]
2. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA. Ann Intern Med; 2001 Jan 16; 134(2):89-95. PubMed ID: 11177311 [Abstract] [Full Text] [Related]
3. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Gurbuz AK, Giardiello FM, Bayless TM. Dis Colon Rectum; 1995 Jan 16; 38(1):37-41. PubMed ID: 7813342 [Abstract] [Full Text] [Related]
4. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature. Chaparro M, Trapero-Marugán M, Guijarro M, López C, Moreno-Otero R, Gisbert JP. J Crohns Colitis; 2013 Mar 16; 7(2):e61-5. PubMed ID: 22552273 [Abstract] [Full Text] [Related]
5. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis. Navaneethan U, Kochhar G, Venkatesh PG, Bennett AE, Rizk M, Shen B, Kiran RP. J Crohns Colitis; 2013 Dec 16; 7(12):974-81. PubMed ID: 23523416 [Abstract] [Full Text] [Related]
6. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM, Rybicki LA, Lashner BA. Aliment Pharmacol Ther; 2005 Nov 01; 22(9):783-8. PubMed ID: 16225486 [Abstract] [Full Text] [Related]
7. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U. J Crohns Colitis; 2013 Dec 01; 7(12):968-73. PubMed ID: 23433613 [Abstract] [Full Text] [Related]
8. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma. Aitola P, Mattila J, Matikainen M. Int J Colorectal Dis; 2000 Jun 01; 15(3):167-71. PubMed ID: 10954188 [Abstract] [Full Text] [Related]
9. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. Zhang R, Wang D, Lauwers GY, Choi WT. Am J Surg Pathol; 2024 Sep 01; 48(9):1154-1163. PubMed ID: 38809303 [Abstract] [Full Text] [Related]
10. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis. Lindström L, Lapidus A, Ost A, Bergquist A. Dis Colon Rectum; 2011 Nov 01; 54(11):1392-7. PubMed ID: 21979184 [Abstract] [Full Text] [Related]
11. [Colorectal cancer in ulcerative colitis]. Laugesen KB, Tøttrup A. Ugeskr Laeger; 2014 Jan 20; 176(4A):V07130441. PubMed ID: 25347248 [Abstract] [Full Text] [Related]
12. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Broomé U, Löfberg R, Veress B, Eriksson LS. Hepatology; 1995 Nov 20; 22(5):1404-8. PubMed ID: 7590655 [Abstract] [Full Text] [Related]
13. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Gastrointest Endosc; 2002 Jul 20; 56(1):48-54. PubMed ID: 12085034 [Abstract] [Full Text] [Related]
14. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis. Poritz LS, Koltun WA. Dis Colon Rectum; 2003 Feb 20; 46(2):173-8. PubMed ID: 12576890 [Abstract] [Full Text] [Related]
15. Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance. Holzmann K, Klump B, Borchard F, Gregor M, Porschen R. Dis Colon Rectum; 2001 Oct 20; 44(10):1446-55. PubMed ID: 11598473 [Abstract] [Full Text] [Related]
16. Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis. Kaplan GG, Heitman SJ, Hilsden RJ, Urbanski S, Myers RP, Lee SS, Burak KW, Swain M, Panaccione R. Inflamm Bowel Dis; 2007 Nov 20; 13(11):1401-7. PubMed ID: 17600816 [Abstract] [Full Text] [Related]
17. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW. Clin Gastroenterol Hepatol; 2012 Mar 20; 10(3):303-8. PubMed ID: 22037429 [Abstract] [Full Text] [Related]
18. [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis]. Yang DH. Korean J Gastroenterol; 2015 Dec 20; 66(6):312-9. PubMed ID: 26691188 [Abstract] [Full Text] [Related]
19. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey. Ünal NG, Özütemiz Ö, Tekin F, Turan İ, Osmanoğlu N. Turk J Gastroenterol; 2019 Feb 20; 30(2):139-147. PubMed ID: 30460897 [Abstract] [Full Text] [Related]
20. Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis. Rabbenou W, Ullman TA. Gastroenterol Clin North Am; 2020 Dec 20; 49(4):791-807. PubMed ID: 33121696 [Abstract] [Full Text] [Related] Page: [Next] [New Search]